MedTrace Logo

Occupational Status and Hematological Disease

NCT02057185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2024-02-07

No results posted yet for this study

Summary

Diseases do not only have a physical role in people's live, but they usually involve changes in life as whole. They may modify the structure of the conjunction with life setting, thus, deeply impacting relationships with others. While clinical results of new therapies for hematological diseases are well documented in scientific literature in terms of prolonged life expectancy or remission from disease, less is known about problems and barriers preventing the return of patients with a chronic blood ailment to everyday life.

Indeed, there are no published data on this topic within the Italian context. The present explorative study aims at identifying the main problems with which patients affected by a Chronic Hematological Disease (CHD) deal when returning to everyday working life, factors associated with work reintegration and, finally, to understand the need for facilitators enhancing reintegration outcomes.

Results from this study will be also helpful to raise consciousness about the problem of reintegration into the labour market of workers with CHD and to call for awareness campaigns for the general public and health professionals.

Conditions

Interventions

BEHAVIORAL

Study questionnaire

Questionnaire based on work situation of enrolled patients.

BEHAVIORAL

SF-36 Questionnaire

Version 1.6

Sponsors & Collaborators

  • Fondazione Adecco per le Pari Opportunità

    collaborator UNKNOWN

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Edoardo La Sala · GIMEMA Foundation

Eligibility

Min Age
15 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-08
Primary Completion
2015-11-11
Completion
2015-11-11

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02057185 on ClinicalTrials.gov